Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01154309 · ClinicalTrials.gov registry record · Phase 1
Group CBT for Depression and AOD Disorders
A Phase 1 study, sponsored by RAND.
- Completed
- Registry status
- Phase 1
- Development phase
- 73
- Enrollment target
NCT01154309 is a Phase 1 study that has completed, run by RAND. The registered enrollment target is 73 participants.
The verdict
NCT01154309, a Phase 1 study, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 73 participants
- Enrollment target
Study Summary
The investigators will adapt and test an existing treatment (group CBT for depression) for use in outpatient substance use treatment settings as delivered by trained substance use counselors. The investigators expect that treatment will lead to improved depression and substance use outcomes.
Interventions
- BEHAVIORAL Group CBT for Depression and AOD Disorders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01154309
The ClinicalTrials.gov registry entry for NCT01154309 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Group CBT for Depression and AOD Disorders is the first listed.
NCT01154309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01154309 about?
NCT01154309 is a clinical study titled "Group CBT for Depression and AOD Disorders". The investigators will adapt and test an existing treatment (group CBT for depression) for use in outpatient substance use treatment settings as delivered by trained substance use counselors. The investigators expect that treatment will lead to improved depression and substance use outcomes.
What is the current status of trial NCT01154309?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 73 participants. The study started on 2006-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT01154309?
The interventions under investigation include: Group CBT for Depression and AOD Disorders (BEHAVIORAL).
Who is sponsoring clinical trial NCT01154309?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.